Neurocrine to Buy Soleno for $2.9 Billion

Date:




Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Mariners crushed again in Bryce Miller start, lose 19-2 to Cubs

Aug 23, 2026, 09:40 PM ETFor Bryce Miller and...

US Treasury to unveil new financial pressure against Iran Monday

'ECONOMIC D-DAY': US Treasury to unveil new financial pressure...

Bret Michaels Forced Off the Road Again After One Comeback Show

After powering his way through a comeback show Friday...